Pharma Leader Series: Top Generic Drug Producers – Leading Companies and Forecasts 2015-2025
By PRN NewsWire
By PRN NewsWire
LONDON, July 27, 2015 /PRNewswire/ —
Prospects for Development, Manufacturing and Business Expansion
Generic Drug Producers – Discover Top Companies’ Revenue Prospects Now, Benefiting Your Influence What does the future hold for manufacturers and sellers of generic medicines [https://www.visiongain.com/Report/1471/Pharma-Leader-Series-Top-Generic-Drug-Producers-Leading-Companies-and-Forecasts-2015-2025 ] ? Visiongain [https://www.visiongain.com ]’s new report shows you leading companies’ prospects to 2025. That study lets you discover results, trends, opportunities and revenue forecasts, helping you stay ahead in knowledge.
For leading producers and marketers of generic drugs, you find information on established and rising companies. Explore their sales potentials in the generics market, seeing from 2015 to 2025 the prospects of industry leaders. What revenues are possible?
Sales predictions and other data to help you stay ahead in competitive intelligence In our study [https://www.visiongain.com/Report/1471/Pharma-Leader-Series-Top-Generic-Drug-Producers-Leading-Companies-and-Forecasts-2015-2025 ] you find analytical profiles of top generics producers. By region you analyse historical data, activities, revenue forecasts and growth rates. Discover qualitative analysis too. That work gives you 82 tables, 87 charts and two interviews with the industry.
Our new analysis [https://www.visiongain.com/Report/1471/Pharma-Leader-Series-Top-Generic-Drug-Producers-Leading-Companies-and-Forecasts-2015-2025 ] shows you the most lucrative parts of the world industry for generic drugs. See today how you can benefit your research, analyses, decisions, proposals and presentations, also saving time and benefiting your reputation for insight.
Assessments of top companies – capabilities, results, competition and sales potentials Our report assesses 43 leading manufacturers of generic medicines worldwide. In general a company profile gives you the following information:
– Discussion of activities, technologies and recent financial results – Assessment of developments – mergers and acquisitions (M&A), new products, outlooks, challenges and plans – Forecasting of generic drug revenues to 2025 (for 19 leading companies).
Discover capabilities, progress and prospects of top generics companies, grouped by region, helping you stay ahead in commercial knowledge and influence. Our study explains the changing generics industry from 2015 to 2025, including opportunities.
For the top 50 generic drug manufacturers in 2014, discover revenues and rankings. Also see top companies’ gross profit margins, EBITDA margins and historical revenue growth.
To see a report overview please email Sara Peerun on email@example.com
The following sections show how our new investigation helps your work.
North America – outlooks for leading generic drug producers and sellers First our report analyses 13 North American generics specialists and big pharma [https://www.visiongain.com/Sector/8/Pharma ] companies in that market, including these firms:
– Mylan – Pfizer – Abbott – Hospira – Apotex – Par Pharmaceuticals
In that analysis [https://www.visiongain.com/Report/1471/Pharma-Leader-Series-Top-Generic-Drug-Producers-Leading-Companies-and-Forecasts-2015-2025 ] you find where revenue growth occurs and how high sales can go. Many opportunities remain, with high, expanding revenues possible from 2015.
Europe – prospects for leading generics players Our survey also shows you outlooks for 10 European generics specialists and pharmaceutical leaders in that industry, including these firms:
– Novartis (Sandoz) – Actavis – Sanofi – Fresenius Kabi – Pharmstandard – Gedeon Richter – Stada Arzneimittel
The report [https://www.visiongain.com/Report/1471/Pharma-Leader-Series-Top-Generic-Drug-Producers-Leading-Companies-and-Forecasts-2015-2025 ] shows you how companies can seize opportunities and expand their businesses from 2015 to 2025. You also examine organisations competing for shares of that expanding, evolving market.
India – analysis of leading generic drug firms Our new work also assesses 10 Indian generic drug producers, including these firms:
– Sun Pharmaceutical Industries – Dr. Reddy’s Laboratories – Lupin – Ranbaxy – Aurobindo – Glenmark – Wockhardt
How much sales growth and geographical expansion can Indian generics companies achieve from 2015? Our study shows you revenue data, trends and prospects, examining what opportunities and potentials exist.
Producers from the rest of world – assess technologies, progress and prospects Our investigation also shows you outlooks for 10 generic drug makers based in other countries, including these companies:
– Teva Pharmaceutical Industries – EMS – Aspen Pharmacare – Nichi-Iko – Abdi Ibrahim – Hypermarcas – Eurofarma – Sawai Pharmaceuticals
Countries such as Japan, Brazil and China will become increasingly important for generic drug development, production and sales from 2015 to 2025, our analyses show.
That work explains forces shaping the generics market and industry [https://www.visiongain.com/Report/1471/Pharma-Leader-Series-Top-Generic-Drug-Producers-Leading-Companies-and-Forecasts-2015-2025 ] , helping you explore changes, challenges and opportunities. Discover what the future holds.
Issues affecting generic drug development, manufacturing and sales Our report discusses issues and events affecting that industry and market from 2015, including these forces:
– Specialty generics – difficult-to-produce medicines with high profit margins – Shift towards innovative and improved drugs, via expanding R&D budgets – Mergers and acquisitions (M&A) influencing that expanding healthcare market – Big pharma firms targeting generics – diversification of product portfolios – International expansion – targeting developed and developing national markets – Intellectual property – regulations, challenges and developments – Biosimilars – opportunities for generic and originator drug companies
There you explore the generic drug industry’s strengths, weaknesses, opportunities and threats. With our study you discover what the future holds for top generic drug producers.
You also gain our interviews with Sanofi Generics and the Generic Pharmaceutical Association (GPhA). Hear what participants think, say and do, helping you stay ahead.
Ways Top Generic Drug Producers – Leading Companies and Forecasts 2015-2025
– Prospects for Development, Manufacturing and Business Expansion helps In particular, our new analysis benefits your work in these five main ways:
– Profiles of 43 generics companies – assess product ranges, strategies and sales results, also gaining revenue forecasts to 2025 for 19 organisations – Competition and opportunities – explore what shapes the generic drugs market’s future, especially companies’ prospects for sustaining and expanding business – Analysis of what benefits and restrains generic drug makers – assess challenges and strengths, helping you compete and gain advantages – Reviews of established competitors and rising players in the generics sector – explore needs, competition, technologies and outlooks for future success – Interviews with authorities – discover what participants in the industry think, say and do, helping you stay ahead in commercial knowledge.
That report, by visiongain [https://www.visiongain.com ]’s in-house analysts in the UK, gives information to benefit your work, saving you hassle and time. You gain data leading companies depend on.
Knowledge found nowhere else, helping your research, analyses and decisions Our investigation gives independent analysis. You receive competitive intelligence found only in that report, discovering generics companies with the most commercial promise.
With our new survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses and decisions. Also find how you can save time and gain in recognition for insight, benefiting your authority.
Predictions for generic drug production and sales – gain by trying our study now Our new analysis shows you data, trends, opportunities and sales forecasts for top producers and sellers of generic drugs. Avoid missing out – please get our report here now.
To see a report overview please email Sara Peerun on firstname.lastname@example.org
Organisations Mentioned in the Report Abbott AbbVie Abdi Ibrahim Abrika Pharmaceuticals Ache Actavis Active Pharma Adcock Ingram Advance Vision Research Aegera Afrexa Life Sciences Agouron Pharmaceuticals Akorn Pharmaceuticals Akrikhin Alcon Allergan Alpharma Alvogen AmerisourceBergen Amide Amneal Pharmaceuticals AMS APL Holdings Limited ApoPharma Apotex Apotex Fermentation APP Pharmaceuticals Aprogen Arrow Group Asahi Kasei Pharma Corporation Ascent Pharmahealth ASKA Pharmaceutical Aspen Aspen Pharmacare Aspen Trading AstraZeneca Auden McKenzie Aurigene Discovery Technologies Auro Pharma Aurobindo Balkanpharma Barr Pharmaceuticals Bausch and Lomb Holdings Bayer Bayer Yakuhin BeiKang Pharmaceutical Bever Biocad Holding Bioniche Pharma Biovena Boca Pharmacal Boehringer Ingelheim Brainfarma Industria e Farmaceutica Bremer Pharma Bunker and Delta Cadila Healthcare Cardinal Health Cenova Pharma CFR Pharmaceuticals Chatted Chattem Chemicals Chimpharm Chiron Corporation Chirotech Technology CIBA VISION Cipla CNS Therapeutics Colotech Cosmed Industria de Cosmeticos e Medicamentos S.A. D. Searle & Company Dabur Pharma DACA Pharmaceuticals Daichi Kasei Dialfor Health DKSH Dr. Reddy’s Laboratories Dream Pharma Dusa Pharmaceuticals EBEWE Pharma Elan Pharmaceuticals Elder Pharmaceuticals Emcure Emergent Biosolutions Emploi Quebec European Medicines Agency EMS Endo Eon Labs Ethics Bio Lab Eurofarma Facet Biotech Fako Fenwal Filaxis Fougera Pharmaceuticals Fresenius Kabi Fuso Pharmaceutical Industries Gangene Corp Gedeon Richter Generic Health Generic Pharmaceutical Association (GPhA) Genfar S.A. Genzyme Germa Pharm GlaxoSmithKline (GSK) Glenmark Globalpharma Golden Cross Pharma Greenstone Handok HealthTronics Helvepharm Herbapol Pruszkow Hexa Hikma Hi-Tech Pharmacal Hospira Hypermarcas IDEV Technologies Ikaria Innopharma Inspire Pharmaceuticals Investissement Quebec Ipca Laboratories J-DOLPH Pharmaceutical Johnson & Johnson JPH Group Holdings Kanghong Sagen Pharmaceuticals Keri Pharma Kilitch Drugs Kolmar Holdings Krka Kunwha Pharmaceuticals Kyowa Pharmaceuticals Labesfal Laboratorio Sanderson Laboratorios Gautier Laboratorios Grin Laboratorios Kendrick Labormed Pharma Leek Lekko Les Laboratoires Servier SAS Lotus Pharmaceuticals Lupin mAbxience Madaus Mallinckrodt Maruko Pharmaceutical Masterlek McKesson Drug Company Mechnikov Biomed Mediate Specialities Medina Medisa Shinyaku Medley Industria Farmaceutica Meiji Seika Pharma Merck & Co Microdose Mitani Sangyo Mitsubishi Tanabe Pharma MJ Pharma Multicare Mylan Laboratories Nanomi B.V National Druggists NBZ Pharma Limited Negma Nichi-Iko Nichi-Iko Pharma Tech Nicox Nippon Chemipher Nippon Kayaku NIXS Corporation Novartis Nycomed Oak Pharmaceuticals OctoPlus Omega Laboratories Limited Onset Dermatologics Onyx Oriel Therapeutics Orion Paladin Labs Par Pharmaceutical Parke-Davis Pendopharm Perrigo Company Pfizer PGT Healthcare Pharma Avalanche Pharmacin Pharmapark Pharmascience Pharmascience Korea PharmaSwiss Pharmstandard Pharmstandard Biotec Phlox Pharma Pinewood Laboratories Piramal Healthcare Solutions Polfa Warszawa Polpharma Pradeep Drug Company Promius Pharma Pymepharco Qalitest Questcor Ranbaxy Laboratories Ranbaxy Life Sciences Research Ratiopharm Ribbon Richter-Helm Roche Romark Laboratories Sabex Sagent Acquisition Corp Salix Pharmaceuticals Sandoz Sanofi Sanofi Pasteur Sawai Pharmaceuticals Schein Pharmaceutical Sekisui Medical Shantha Biotechnics Silom Medical Company Sindan Solus Pharmaceuticals Solvay Pharmaceuticals Somar Specifar Pharmaceuticals S.A. SPIL de Mexico Spirig Pharma Stada Arzneimittel STARLIMS Sun Pharmaceutical Swisse Wellness Taiyo Cephalon Taro Technologies Inc Teikoku Medix Terapia S.A. Teva Pharmaceutical Industries The European Generic Medicines Association (EGA) The Generic Pharmaceutical Association TKS Pharmaceutical Torrent Pharmaceuticals Towa UDL Laboratories United Research Laboratories URL Pharma US Food and Drug Administration (FDA) Uteron Pharma S.A. Valeant Velefarm Veropharm VersaPharm Incorporated Vindexpharm VPI Holdings Corp Warner Chilcott Warner Lambert Watson Pharmaceuticals Winthrop Wockhardt Wyeth Yakuhan Pharmaceuticals ZAO Ranbaxy Zao Sun Pharma Zhejiang Chiral Medicine Chemicals Company ZiO Zdorovje Zoetis Zydus Pharmaceuticals Zydus Wellness To request an exec summary of this report please email Sara Peerun at email@example.com or call Tel: +44(0)20-7336-6100 Or click on https://goo.gl/hmzcPM